denenicokin
Recombinant proteinexperimental
Clinical trial activity
10 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2004 (NCT00095108)
Timeline
Indications
Mechanism of action
- Interleukin-21Supplementation
IL21 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2107855 ↗
Also known as
- denenicokin
- denenicokin
- denenicokin
- il21
- il-21
- il-21
- il-21
- il21 protein, human
- interleukin 21
- interleukin-21
- interleukin-21
- interleukin 21 protein, human
- recombinant human interleukin 21
- ril-21
- ril-21; recombinant human interleukin 21
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01629758 | Phase 1 | Jun 1, 2012 | Bristol-Myers Squibb |
| NCT01152788 | Phase 2 | Jun 1, 2010 | British Columbia Cancer Agency, Canadian Cancer Trials Group, University of Toronto |
| NCT00601861 | Phase 2 | Feb 13, 2008 | Novo Nordisk |
| NCT00523380 | Phase 2 | Oct 4, 2007 | Novo Nordisk |
| NCT00617253 | Phase 2 | Jul 12, 2007 | Novo Nordisk |
| NCT00514085 | Phase 2 | Jul 1, 2007 | Canadian Cancer Trials Group, University of Toronto |
| NCT00389285 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2006 | ZymoGenetics |
| NCT00347971 | Phase 1 | Jun 1, 2006 | ZymoGenetics |
| NCT00336986 | Phase 2 | Sep 1, 2004 | Novo Nordisk |
| NCT00095108 | Phase 1 | May 1, 2004 | ZymoGenetics |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novo Nordisk | For profit | 4 | 4 | 1 | 2004 |
| ZymoGenetics | For profit | 3 | 3 | 2 | 2004 |
| Canadian Cancer Trials Group | Academic/Hospital | 2 | 2 | 1 | 2007 |
| University of Toronto | Academic/Hospital | 2 | 0 | 1 | 2007 |
| Bristol-Myers Squibb | For profit | 1 | 1 | 1 | 2012 |
| British Columbia Cancer Agency | Academic/Hospital | 1 | 0 | 1 | 2010 |
6 organizations
Page 1 / 1